Skip to main content
. Author manuscript; available in PMC: 2015 Jul 7.
Published in final edited form as: AIDS. 2013 Jul 31;27(12):1899–1909. doi: 10.1097/QAD.0b013e3283610ec7

Fig. 1. Summary of drug resistance genotype testing performed on treatment-naive and treatment-experienced HIV-infected patients at the Joint Clinical Research Centre (JCRC), Kampala, Uganda over a 10-year period.

Fig. 1

The number of drug resistance genotypes (DRGs) performed on samples from treatment failures (a and b) and treatment-naive patients (c and d) over the past 10 years are presented as a percentage with at least one primary drug-resistant mutation (a and c) or based on the infecting HIV-1 subtype in the sample (b and d).